MYCOF

Mydecine Innovations Group Inc. MYCOF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode MYCOF CHHE TELIF LUFFF OASMY BTCY QPTFF PTKFY GLABF VPHIF
6M 3 105.88 % -99.95 % -10.23 % 321.05 % -75.00 % -15.93 % 200.75 % -25.58 % -88.53 % -99.79 %
YTD 1 701.65 % -99.96 % -13.72 % -25.16 % -87.50 % 19.35 % 200.75 % -34.94 % -87.15 % -99.79 %
1Y 2 625.00 % -99.96 % -7.80 % 263.64 % -90.00 % 31.30 % 200.75 % -34.94 % -81.03 % -99.79 %
3Y -71.32 % -99.94 % 1.57 % -93.33 % -90.00 % -89.55 % -47.51 % -47.33 % -67.89 % -99.98 %
5Y -68.22 % -99.97 % -50.33 % -99.10 % -99.66 % -92.29 % -76.42 % -37.87 % -83.29 % -99.99 %
10Y -68.22 % -99.90 % -50.33 % -95.56 % -99.86 % -97.67 % -70.95 % -26.63 % -83.29 % -99.99 %
From the beginning -68.22 % -99.00 % -50.33 % -100.00 % -99.87 % -97.67 % -70.95 % -27.11 % -83.29 % -99.99 %

Dividend

Vivesto AB

PT Kalbe Farma Tbk.